LJC 10627

Known as: LJC-10627, LJC10,627 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

biapenem

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
The activity of biapenem (L-627, LJC-10627), a new carbapenem, was investigated against Pseudomonas aeruginosa strains, mutants… (More)
Is this relevant?
1991
1991
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
The activity of LJC10,627 was compared with the activities of imipenem and other antibiotics. LJC10,627 was more active against… (More)
Is this relevant?
1990
1990
In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
The in vitro activity of LJC10,627, a new carbapenem, was compared with those of imipenem and ceftazidime. LJC10,627 had broad… (More)
Is this relevant?
1990
1990
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627
In in vitro susceptibility tests the new carbapenem LJC10,627 showed potent antibacterial activity against gram-positive and gram… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?